Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Obstetrix One is a premium prenatal and postnatal multivitamin and mineral supplement developed by Seyer Pharmatec. It is formulated as a gelatin-coated softgel capsule containing a comprehensive blend of essential nutrients, including calcium ascorbate dihydrate, cholecalciferol (vitamin D), d-alpha tocopheryl acetate (vitamin E), pyridoxine hydrochloride (vitamin B6), calcium l-5-methyltetrahydrofolate (Metafolin), cyanocobalamin (vitamin B12), carbonyl iron, magnesium oxide, zinc oxide, and docosahexaenoic acid (DHA). The supplement is designed to support maternal health and fetal development during pregnancy and the postnatal period, while specifically aiming to reduce common side effects associated with prenatal supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Obstetrix One.